These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Kim H, Chun S, Ku SY, Suh CS, Choi YM, Kim JG. Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902 [Abstract] [Full Text] [Related]
5. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Arko B, Prezelj J, Kocijancic A, Komel R, Marc J. Maturitas; 2005 Jul 16; 51(3):270-9. PubMed ID: 15978970 [Abstract] [Full Text] [Related]
6. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee KM, Lee KH, Kang C, Cho DY, Kang D. Calcif Tissue Int; 2005 Sep 16; 77(3):152-9. PubMed ID: 16151677 [Abstract] [Full Text] [Related]
7. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone. Han KO, Choi JT, Choi HA, Moon IG, Yim CH, Park WK, Yoon HK, Han IK. Clin Endocrinol (Oxf); 2005 Mar 16; 62(3):349-53. PubMed ID: 15730418 [Abstract] [Full Text] [Related]
8. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. Oh KW, Rhee EJ, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Choi MG, Yoo HJ, Park SW. Clin Endocrinol (Oxf); 2004 Aug 16; 61(2):244-9. PubMed ID: 15272921 [Abstract] [Full Text] [Related]
12. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, Vierucci S, Brandi ML, Falcini F. J Rheumatol; 2004 May 16; 31(5):986-91. PubMed ID: 15124262 [Abstract] [Full Text] [Related]
14. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Yamada Y, Ando F, Niino N, Shimokata H. Mol Genet Metab; 2003 Nov 16; 80(3):344-9. PubMed ID: 14680982 [Abstract] [Full Text] [Related]
17. [Study of the impact of candidate genes on bone mineral density in postmenopausal women]. Zhao HY, Liu JM, Ning G, Zhang LZ, Song HD, Chen Y, Jiang L, Dai M, Xu MY, Chen JL. Zhonghua Fu Chan Ke Za Zhi; 2005 Dec 16; 40(12):803-7. PubMed ID: 16412323 [Abstract] [Full Text] [Related]
19. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C. Bone; 2004 Sep 16; 35(3):785-91. PubMed ID: 15336617 [Abstract] [Full Text] [Related]
20. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. Mencej-Bedrac S, Prezelj J, Kocjan T, Teskac K, Ostanek B, Smelcer M, Marc J. J Mol Endocrinol; 2009 Mar 16; 42(3):239-47. PubMed ID: 19131500 [Abstract] [Full Text] [Related] Page: [Next] [New Search]